HTGM Htg Molecular Diagnostics Inc

HTG Molecular Diagnostics Inc is a commercial stage company. It develops & markets a novel technology platform to facilitate the routine use of complex molecular profiling with its focus on clinical applications.

$0.54  -0.03 (-4.85%)
As of 05/26/2022 16:00:00 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  05/06/2015
Outstanding shares:  8,586,046
Average volume:  660,576
Market cap:   $4,872,581
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -0.25
PB ratio:   0.41
PS ratio:   0.56
Return on equity:   -180.72%
Net income %:   -217.12%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy